A r t i c l e s
Skeletal muscles constitute the most abundant tissue in the human body. Several degenerative diseases of the muscle, such as DMD, may be treatable with cell therapy approaches if healthy muscle progenitors could be grafted in patients to recreate lost muscles and resident stem cells 1 . Efficient generation of functional muscle cells in vitro from pluripotent cells has so far been achieved only by introducing exogenous DNA into the cells to force expression of transcription factors such as Myod1, Pax3 and Pax7 (refs. 2-7) . Embryoid bodies generated from mouse ES cells in various conditions can differentiate into a wide range of cell types derived from the three germ layers, including skeletal muscle [8] [9] [10] . However, this strategy allows poor control and reproducibility of the differentiation process and usually yields mixed populations with low percentages of the target cell population. In several recent studies using embryoid bodies to produce skeletal muscle from mouse or human pluripotent cells, neither the differentiation efficiency nor the degree of differentiation has been documented [11] [12] [13] [14] [15] [16] . An alternative approach-differentiation of pluripotent cells in monolayers by modulation of signaling pathways to induce a paraxial mesoderm fate [17] [18] [19] [20] [21] [22] [23] [24] -has led mostly to limited production of paraxial mesoderm precursors, necessitating enrichment by cell sorting. Furthermore, these studies have not shown production of contractile millimeter-size fibers with organized myofibrils and their associated satellite muscle stem cells in their niche.
Here we recapitulate the development of the muscle lineage in vitro from mouse and human pluripotent stem cells to produce multinucleated muscle fibers with organized myofibrils and Pax7 + cells exhibiting characteristics of satellite cells. The Pax7 + cells are able to reconstitute muscle fibers and satellite cells when grafted into the muscle of mdx mice, which lack dystrophin, the protein mutated in DMD. mdx muscle fibers differentiated from ES cells in vitro show a striking increase in the number of branches, reminiscent of that observed in individuals with DMD.
RESULTS

Transcriptome landscape during PSM differentiation
We first set out to recapitulate the early stages of differentiation of the myogenic lineage in the PSM. The posterior-to-anterior maturation gradient of the PSM means that within a single embryo the different stages of differentiation are spatially mapped out along the posterior-toanterior axis. We therefore profiled the full process of differentiation from the tail bud stage to the onset of myogenesis by microarray analysis of consecutive fragments stretching from the tail bud to the newly formed somite of embryonic day (E)9.5 mouse embryos (Fig. 1a,b and Supplementary Fig. 1 ). The resulting representation of gene expression along the PSM during early stages of paraxial mesoderm differentiation was consistent with data from in situ hybridization, as exemplified by During embryonic development, skeletal muscles arise from somites, which derive from the presomitic mesoderm (PSM). Using PSM development as a guide, we establish conditions for the differentiation of monolayer cultures of mouse embryonic stem (ES) cells into PSM-like cells without the introduction of transgenes or cell sorting. We show that primary and secondary skeletal myogenesis can be recapitulated in vitro from the PSM-like cells, providing an efficient, serum-free protocol for the generation of striated, contractile fibers from mouse and human pluripotent cells. The mouse ES cells also differentiate into Pax7 + cells with satellite cell characteristics, including the ability to form dystrophin + fibers when grafted into muscles of dystrophin-deficient mdx mice, a model of Duchenne muscular dystrophy (DMD). Fibers derived from ES cells of mdx mice exhibit an abnormal branched phenotype resembling that described in vivo, thus providing an attractive model to study the origin of the pathological defects associated with DMD.
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well-characterized genes such as the fibroblast growth factor (FGF) ligand Fgf8 and the retinoic acid biosynthetic enzyme Raldh2 (also known as Aldh1a2), which show anterior or posterior graded expression in the PSM, and by Mesp2, which shows a striped expression (Fig. 1c) .
Clustering analysis revealed that the mouse PSM can be subdivided into anterior and posterior transcriptional domains (Fig. 1d) , as previously reported for zebrafish 25 . A comparison of gene expression fold changes between the two domains ( Fig. 1e) identified 285 genes upregulated in the anterior PSM and 330 in the posterior PSM with a fold change >2 (P < 0.05). These included most genes known to be specific for either anterior or posterior PSM, such as Msgn1 and Pax3, respectively ( Fig. 1e and Supplementary Table 1 ).
Wnt activation and BMP inhibition lead to a PSM fate
We reasoned that a successful myogenic differentiation protocol might have to mimic these important transitions of the developing PSM. To monitor the differentiation of ES cells toward the posterior PSM fate, we generated a transgenic mouse ES cell line (Msgn1-repV for Mesogenin1 reporter Venus) in which the promoter of the posterior PSM-specific gene Msgn1 (ref. 26 ) drives expression of Venus fluorescent protein. Embryos generated by tetraploid aggregation from Msgn1-repV cells faithfully expressed the reporter in the posterior PSM (Fig. 2a) . To identify secreted factors able to guide differentiation of ES cells toward the posterior PSM fate, we searched the microarray series for secreted factors specifically expressed in this domain. One such factor showing strong enrichment in the posterior PSM was the Wnt activator R-spondin3 (Rspo3) 27 ( Fig. 1e and Supplementary Table 1) . By in situ hybridization, Rspo3 exhibited a graded expression specific to the posterior PSM (Fig. 2b) . When monolayers of Msgn1-repV cells were cultured in serum-free medium supplemented with Rspo3 and the Bmp inhibitor LDN193189 ('RDL' medium, to block lateral plate mesoderm induction 28 ), large numbers (45-65%) of Venus + (M + ) cells were observed after 4 d of differentiation (Fig. 2c) . M + cells generated in RDL medium showed strong upregulation of TB1-1  TB1-2  TB1-2  PSM2-1  PSM2-2  PSM2-3  PSM3-1  PSM3-2  PSM3-3  PSM4-1  PSM4-2  PSM4-3  PSM5-1  PSM5-2  PSM5-3  PSM6-1  PSM6-2  PSM6-3  SOM7-1  SOM7- (Fig. 1d) . The ratio of expression for each probe set is plotted on x axis (fold change, logarithmic scale); its significance on the y axis (t-test P value, logarithmic scale). Total probe sets shown are about 45,000 from which about 15,000 are considered significant (P < 0.05). Well-characterized signature genes enriched in the pPSM (in green) and in the aPSM (in blue) are shown. Note that Rspo3 (underlined, in green) is significantly upregulated in the pPSM.
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A r t i c l e s the paraxial mesoderm markers Tbx6, Hes7 and Msgn1, and very low levels of the lateral plate marker Foxf1a (also known as Foxf1) and of the cardiac marker Nkx2-5 ( Fig. 2d) . At day 4, a majority of the M + cells also expressed the PSM-marker Tbx6 (Fig. 2g) .
We next compared the transcriptional identity of the M + cells cultured in serum-free RDL medium for 4 d to their in vivo counterparts, the posterior PSM cells (Figs. 1d and 2i) The ratio of expression for each probe set and for each comparison is plotted on x axis and y axis, respectively (fold change, logarithmic scale). Probe sets (about 3,400) with a t-test P < 0.05 ( Fig. 1e) are shown. Green, known signature genes specific for the pPSM. (j) FcFc scatter plot comparing FACS-sorted P + cells differentiated for 6 d in RDL medium to ES cells and aPSM microarrays to ESC microarray expression data sets. The ratio of expression for each probe sets for each comparison is plotted on x axis and y axis, respectively (fold change, logarithmic scale). Probe sets (about 3,400) with a t-test P < 0.05 (Fig. 1e) are shown. Blue, known signature genes specific for the aPSM. npg a posterior PSM-like fate. As Rspo3 is a Wnt activator, we replaced it with the GSK3β inhibitor CHIRON99021 (Chir), which also activates the Wnt pathway, in the differentiation medium (CDL). This led to similar induction of Msgn1 + cells (Fig. 2c) , which, when analyzed using quantitative real time PCR (qRT-PCR) and microarrays, showed a very similar profile to the cells differentiated in RDL medium ( Fig. 2d and Supplementary Fig. 2 ).
In vivo, as paraxial mesoderm cells mature, they become located in the anterior PSM and downregulate expression of the posterior PSM markers Msgn1 and Tbx6 while activating expression of Pax3, an early and essential myogenic inducer expressed in the anterior PSM and in myogenic precursors 29 (Figs. 1b and 2a) . A similar dynamic was observed in culture in RDL or CDL medium as by day 5 of differentiation M + cells became Pax3 + while downregulating Tbx6, suggesting acquisition of an anterior PSM fate (Fig. 2g) . To monitor the differentiation of ES cells toward the anterior PSM fate, we generated a mouse ES reporter line (Pax3-GFP) in which GFP was placed under the control of Pax3 regulatory sequences. When these reporter cells were cultured in RDL or CDL medium, ~30-50% of cells were GFP + after 6 d of differentiation (Fig. 2c) . By qRT-PCR, the Pax3-GFP + (P + ) cells were essentially negative for the neural marker Sox2 (Fig. 2e) , but positive for the anterior PSM/somitic markers Pax3, Tbx18, Meox2 and Uncx (Fig. 2e,f) , thus excluding a neural origin for these cells. Expression levels of these genes were similar to endogenous expression levels in mouse embryonic tails (Fig. 2f) . Furthermore, these cells expressed Pax3 ( Fig. 2h) and had a typical mesenchymal morphology different from that of the epithelial rosetteforming neural precursors expressing Pax3 observed in neuralinducing conditions (data not shown).
A comparison of global gene expression in P + cells differentiated in RDL medium and in the anterior PSM showed that during in vitro differentiation ES cells upregulated a large number of anterior PSM signature genes, including Ripply2, Meox2, Pax3, Foxc2, Cer1 and Dmrt2 ( Fig. 2j and Supplementary Table 3 ). Very similar differentiation profiles were observed in P + cells differentiated in CDL medium ( Fig. 2f and Supplementary Fig. 2 ). Thus, in vitro differentiation of the Msgn1-repV and the Pax3-GFP reporter ES cells in the presence of Wnt activators and BMP inhibitor efficiently recapitulates early differentiation stages of the paraxial mesoderm in the PSM, providing a scalable protocol for the generation of large numbers of cells that closely resemble the precursors of myogenic cells in vivo. 
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Recapitulation of primary fetal myogenesis in vitro
We next sought to define conditions to reproducibly differentiate the anterior PSM-like cells to skeletal muscle. During embryogenesis, the formation of muscle fibers starts with primary myogenesis, when muscle fibers expressing slow myosin heavy chain (MyHC) and harboring a small number of nuclei form from Pax3 + precursors. This phase is then followed by fetal or secondary myogenesis, when Pax7 + myogenic precursors derived from the Pax3 + population fuse to form larger fibers harboring a large number of nuclei and expressing more mature MyHC isoforms, such as fast MyHC 29 . ES cells were differentiated in RDL or CDL medium for 6 d and then cultured in medium containing the myogenesis-promoting factors hepatocyte growth factor (HGF), insulin growth factor 1 (IGF-1) and fibroblast growth factor 2 (FGF-2) 30 for up to 2 months (Fig. 3a) . At day 9, differentiating cells had downregulated Pax3 and begun to activate Pax7, as is observed for myogenic precursors in vivo 29 . At this stage, many cells had differentiated into proliferating myoblasts (Myod1 + , Fig. 3b ) and myocytes (Myog + , Fig. 3b ). At day 10, the Myogenin + population accounted for 25-30% of the cells (Fig. 2c) .
To monitor the appearance of committed skeletal muscle cells, we generated a reporter ES cell line, Myog-repV, harboring a 1.6-kb fragment of the Myogenin1 promoter fused to Venus. Venus + myocytes with a single centrally located nucleus (Fig. 3d, arrowheads) , strongly resembling early myotome cells produced during primary myogenesis, were detected after 1 week in culture. The number of cells expressing Pax7, Myod1, Myog and fast MyHC steadily increased during the second week of differentiation, covering large areas of the culture (Fig. 3c) . The Myog-repV + primary myocytes progressively fused to produce fast MyHC + myotubes (Fig. 3e) , extending up to several hundred micrometers by 10 d (data not shown). These results suggest that our protocol recapitulates essential steps of primary myogenesis.
After 2-3 weeks of culture, several thousand multinucleated laminin + and dystrophin + fibers expressing fast MyHC were observed per square centimeter in the cultures (Fig. 3f-i and Supplementary Table 4) . After 3-4 weeks, the more mature (larger) fibers contained ~25-50 myonuclei, a number similar to that found in perinatal fibers 31 (Supplementary Table 4) . We compared by qRT-PCR the expression of a set of myogenic markers in 3-week-old cultures differentiated in the conditions described above (Fig. 3a) with cultures of undifferentiated ES cells, and with mouse E11.5 trunk muscles (containing primary myofibers) and E17.5 back muscles (in which secondary, fetal myogenesis is ongoing) (Fig. 3j) . Notably, the marker of fetal muscle fibers Nfix 32 and the Fast2A (Myh2) myosin heavy chain were not observed in E11.5 trunk muscles but were significantly enriched both in the E17.5 muscle sample and in the 25-day-old cultures ( Fig. 3j ; P < 0.005). The muscle fibers differentiated in culture for 3 to 4 weeks reached a density of ~40 fibers per square millimeter, with local fiber patches density reaching 300 + fibers per square millimeter (Supplementary Table 4) . Immuno-labeling with anti-fast MyHC antibody showed that these fibers exhibited highly organized striation as expected in mature muscle fibers (Fig. 3k) . Differentiated fibers exhibited spontaneous in vitro contractions, indicating that the sarcomeric organization of the fibers was functional (data not shown). The fibers were >1 mm in length and ~11 µm in width, with a sarcomeric length of ~2.4 µm, similar to the dimensions of post-natal fibers in vivo 31 (Supplementary Table 4) . Thus, our differentiation protocol recapitulates both primary and fetal (secondary) skeletal myogenesis, producing striated contractile muscle fibers exhibiting a phenotype similar to that of early post-natal fibers.
Satellite cell-like properties of Pax7 + cells In 3-week-old cultures, a population of small cells expressing Pax7 was found interspersed with the fast MyHC + fibers, as expected for myogenic precursors and satellite cells 33, 34 (Fig. 3l) . After 3-4 weeks in culture, the number of Pax7 + cells decreased, and those that remained were tightly associated with the myofibers (Fig. 3l) . Many of these cells were Ki67 − , suggesting that they had exited the cell cycle (data not shown), and they were sometimes found enclosed in the laminin + basal lamina surrounding the muscle fibers, as expected for satellite cells (Fig. 3m,n) .
These data suggested that cells in the mature myogenic cultures spontaneously organized to recreate a niche for satellite cells. To test whether the Pax7 + cells had properties of satellite cells, we generated a mouse Pax7-GFP transgenic ES cell reporter line in which GFP expression is driven by a Pax7 bacterial artificial chromosome transgene. We also introduced a ubiquitous reporter, CAGGS-CFP, in these cells to permanently track their progeny in grafting experiments. We differentiated these cells for 3-4 weeks according to the protocol described above and sorted the Pax7-GFP + cells by flow cytometry, which represented about 0.5% of the total single-cell population. Next we grafted ~1 × 10 5 cells into the tibialis anterior muscle of adult Rag1 −/− Dmd mdx-5Cv (mdx) mice, which are immunodeficient mice lacking dystrophin. One month after injection, the GFP-expressing donor cells had generated foci of fibers that were fast MyHC + (Fig. 4a,b ) and dystrophin + (Fig. 4c,d) . The grafted cells also gave rise to Pax7 + satellite cell-like cells located under the basal lamina of GFP + fibers ( Fig. 4e-g ). The donor-derived fibers were well aligned with host fibers and had a smaller cross-sectional area compared with host GFP − fibers ( Fig. 4a-d) . These experiments demonstrate that the Pax7 + cells generated in vitro can behave as satellite cells when grafted in a dystrophin-deficient environment.
Branching of differentiated dystrophin-deficient fibers
We next derived ES cell lines from blastocysts of mdx mice. After 3-5 weeks of myogenic differentiation in vitro in the serum-free conditions described above (Fig. 3a) , mdx ES cells differentiated to mature muscle fibers. Multinucleated mdx fibers reached up to 1.2 mm in length, with an average diameter of 10.5 µm, values similar to those of the control fibers. Spontaneously contracting fibers were also observed in differentiated mdx ES cell cultures (data not shown). It has been suggested that lack of dystrophin weakens the fiber membrane, causing it to tear upon contraction and leading ultimately to fiber necrosis 35, 36 . To test whether in vitro-generated mdx fibers exhibit defects in membrane integrity, we stained 3-to 4-week-old fibers with Evans blue 37 . Dye uptake was not detected in mdx or in control fibers, whereas it was observed following membrane permeabilization with saponin, suggesting that membrane integrity was not impaired (Supplementary Fig. 3 ). However, ~30% of the mdx muscle fibers had one or more lateral branches (Fig. 5b,d ,e) compared to only ~10% of control fibers (Fig. 5a,c) . Fibers with multiple branches, which created a star-like aspect, were essentially restricted to mdx cultures ( Fig. 5d,e ; P < 0.005). Although sarcomeres appeared grossly normal, with an average length of 2.4 µm, bundling of the myofibrils along the mdx fibers was often disrupted, presenting tilts or twists (Fig. 5d) resembling those reported for mdx fibers in vivo 38 .
Myogenic differentiation of human iPS cells
Finally, we adapted our myogenic differentiation conditions to human induced pluripotent stem (hiPS) cells. We first cultured hiPS cells as single cells for 6 d in serum-free medium containing Chir and LDN193189, followed by culture in serum-free medium containing IGF-1, HGF and FGF-2 growth factors (Fig. 6a) . After 20 d, the cultures contained large fields comprising fast MyHC + (Fig. 6b,e) and Myogenin + (Fig. 6c) fibers and PAX7 + cells (Fig. 6d) . Between 20 and 30 d of culture, large numbers of MyHC + fibers more than one mm long intermingled with PAX7 + cells appeared (Fig. 6d-f, data not shown) . By 4 weeks, ~22% of nuclei were MYOG + and 23% of nuclei were PAX7 + . The muscle fibers showed organized sarcomeres, as demonstrated by the periodic distribution of the sarcomeric proteins Titin and fast MyHC (Fig. 6h-j) . Furthermore, 
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A r t i c l e s these striated fibers exhibited spontaneous twitching, indicating that their sarcomeric organization was functional (Supplementary  Movie 1) . The diameter of the human muscle fibers generated in vitro was ~3.5 µm, that is, smaller than that of mouse fibers despite a similar length (Supplementary Table 4) . Many of the PAX7 + cells were also Ki67 − and were often found lining the MyHC + fibers (Fig. 6f) . The total number of PAX7 + cells strongly decreased after 40 d down to ~1% at day 50.
With mouse cells, 7,000-10,000 multinucleated muscle fibers could be obtained in wells initially seeded with 20,000 ES cells, whereas with human cells we obtained around 50,000-70,000 fibers starting from 75,000 hiPS cells. These yields compare well with current cardiomyocyte differentiation protocols (Supplementary Table 4) 39 . Similar differentiation efficiencies were also observed with the human ES cell line H9 (data not shown). We directly compared our protocol with that of reference 24, in which no BMP inhibitor was added in the first phase of the culture. After 30 d we were unable to detect significant amounts of MyHC + fibers or PAX7 + cells in hiPS cells cultured with these conditions. Small fast MyHC + myotubes were detected only after 50 d in culture, but they did not show any striation (Supplementary Fig. 4 ).
DISCUSSION
Difficulties in differentiating human pluripotent cells toward a myogenic fate have hampered the development of in vitro models of muscle diseases such as sarcopenia, cachexia and muscular dystrophies. Here we report the in vitro differentiation of mouse and human pluripotent cells into striated, linear, millimeter-long muscle fibers. The fibers can contract, and they provide a niche that supports the emergence of Pax7 + cells that resemble satellite cells. The Pax7 + cells are mostly found along the membrane of differentiated muscle fibers, often under the laminin + basal lamina, and a majority of them are quiescent, as expected for satellite cells. Such fibers do not form in standard myoblast monolayer cultures, in which much shorter, irregularly shaped myotubes lacking striation are usually observed. One reason for the difference between these two types of culture might be that our protocol recapitulates the entire myogenic developmental sequence. In vivo, primary fibers serve as a scaffold for secondary fibers, which organize the linear fusion of myoblastic cells to form adult muscle fibers 40 . In our cultures, we observe formation of primary and secondary muscle fibers, suggesting that such a morphogenetic sequence takes place. These events might also be critical to the emergence of Pax7 + cells with satellite cell properties. Similar self-organizing processes in differentiated ES cell cultures are now widely recognized for a number of structures, such as the retina 41 and the gut 42 , and thus likely occur for muscle tissue as well.
We used four fluorescent reporter ES cell lines to systematically optimize the differentiation of mouse ES cells toward a paraxial mesoderm fate on the basis of developmental cues. Transposition of the protocol to human pluripotent cells required several modifications but retained the key elements of the mouse method. In particular, human ES cells being equivalent to mouse epiblast cells 43 , the first step of the mouse protocol aimed at inducing epiblast from 'naive' mouse ES cells was unnecessary. Thus, hiPS cells were directly exposed to Wnt activation and to inhibition of the BMP pathway. We found that strong BMP inhibition at this stage is critical, as otherwise cells begin to express BMP4 and drift to a lateral plate fate (data not shown). This step represents a major difference from protocols for paraxial mesoderm induction in which only Wnt signaling is activated 14, 20, [22] [23] [24] . We also found that early addition of FGF-2 is beneficial to the survival and proliferation of the human pluripotent cells. After mouse and human pluripotent cells were induced to a mature PSM fate, exposure to the three myogenic growth factors HGF, IGF-1 and FGF-2 (ref. 30) resulted in myogenesis. Mouse myotubes were detected after 1 -2 weeks of differentiation, whereas human cell cultures required ~3 weeks, consistent with the generally slower differentiation of human pluripotent cells compared with mouse ES cells. Although virtually nothing is known about the early stages of paraxial mesoderm development and myogenesis in humans, our data suggest that signaling cues similar to those described for mouse are deployed during development of the human muscle lineage.
Our work on mdx ES cells suggests that dystrophin is required for normal morphogenesis of muscle fibers, at least in culture 44 , and provides a tractable in vitro model to study the cell biology of DMD. Increased branching of myofibers has been reported in DMD patients, in embryonic and adult mdx mice and in mice lacking the olfactory receptor MOR23 or the intermediate filament desmin [44] [45] [46] [47] . In adult mdx mice, increased branching has been proposed to result from abnormal fiber morphogenesis caused by defective myoblast fusion arising during the regeneration process stimulated by fiber degeneration 36, 45, 47 . However, the increased branching of mdx fibers differentiated from ES cells in vitro was unexpected as such a phenotype has not been reported in primary mdx myoblast cultures or in human DMD myoblast cultures. Our observation of a branching defect may be explained by the capacity of cells generated by the present protocol to self-organize into long fibers. Our model will allow analysis of whether this defect originates in fusion of myogenic precursors.
Healthy muscle precursors grafted into mdx mice give rise to considerable numbers of dystrophin-expressing fibers 48 . However, clinical trials using human myoblasts amplified in vitro have failed owing to poor engraftment of the cells 49 . Mouse studies to date have established that the cell type with the best regenerative properties is the Pax7 + satellite cell 48, 50 . Our protocol for differentiating mouse ES cells to a muscle fate produces Pax7 + satellite cell-like cells capable of generating dystrophin + muscle fibers and their associated satellite cells when grafted in mdx mice muscle. Further optimization of the protocol for human pluripotent cells may facilitate the development of cell therapies for DMD and other degenerative diseases of the muscle.
METhODS
Methods and any associated references are available in the online version of the paper.
Accession codes. GEO: GSE39615.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METhODS
Generation of mouse reporter and mdx ES cell line. Msgn1-repV line. The Msgn1-repV transgene consists of a 6.5-kb fragment of the mouse Mesogenin1 promoter 26 inserted upstream of the Venus (YFP) coding sequence 52 followed by the SV40 poly-adenylation sequence and a neomycin resistance cassette flanked by FRT sites. Mouse ES cells (E14, 129P2 genetic background, BayGenomics) were transfected with the linearized construct using Lipofectamin (Invitrogen). Clones were selected for Neomycin resistance and validated by the tetraploid aggregation technique as described 53 . One clone, called Msgn1-repV, showing the appropriate expression pattern was selected for further studies.
Pax3-GFP line. Pax3-GFP ES cells were generated by homologous recombination using a targeting construct derived from that described in 54 . Briefly, the Pax3-GFP (Gene X-IRESnLacZ) allele contains 2.4 kb of the 5′ genomic region of Pax3, but lacks the coding sequence of exon 1, and 4 kb of the 3′ sequence which contains exons 2-4. The insert construct is composed of the coding sequence for GFP, followed by a Puromycin selection cassette flanked by FRT sites. The targeting vector was electroporated into CK 35 ES cells (129Sv genetic background) 55 . ES cells were selected and screened for recombination events by Southern blot analysis using EcoRV digestion and a 5′-flanking probe. The positive clones were further verified by using 3′ external and internal probes. Targeted ES cells were recovered with a 0.5% frequency, and efficient germline transmission was used to assay cells' pluripotency. In order to generate Pax3-GFP ES cells, targeted ES cells were electroporated with a construct containing the FLP recombinase.
Myog-repV line. The same strategy as for Msgn1-repV was used with the Myog-repV transgene using a 1.6-kb fragment of the mouse Myogenin promoter 56 . One clone, called Myog-repV, showed colocalization of the fluorescent reporter with the endogenous Myogenin protein in myocytes differentiated from embryoid bodies as described 9 and was selected for further studies.
Pax7-GFP blue line. Pax7-GFP mES clones were derived from the transgenic mice Tg: Pax7-nGFP described in 57 . Cells were cultured in medium containing 1 µM PD0325901 (Tocris, Stemgent) and 3 µM CHIRON99021 (Chir, Tocris, Stemgent) (2i medium) as described 58 . Cells were transfected with an ubiquitous reporter construct composed of CAGG-nlsCFP followed by the SV40 poly-adenylation sequence and a puromycin resistance cassette flanked by FRT sites. Picked clones were isolated and further amplified by passages in 2i medium. Two clones were further selected for myogenic differentiation and grafting experiments. The Pax7-GFP label is necessary to sort the cells to be grafted and the CFP label is required to track the descendants of these cells in the host. Thus muscle fibers deriving from the grafted Pax7 + cells are expected to express only CFP whereas satellite cells derived from the grafted cells are expected to express both GFP and CFP. While GFP and CFP expression is expected to be nuclear we have observed leakage of the fluorescent proteins to the sarcoplasm of muscle fibers in which both cytoplasmic and nuclear staining was observed.
Mdx ES cells. mdx mES clones were derived from the dystrophin mutant mdx homozygous/hemizygous blastocysts of the C57BL/10 genetic background (Jackson laboratory) cultured in 2i medium as described 58 . Ten clones were isolated by picking and further amplified by passages in 2i medium. Two clones (male, hemizygous) were further selected for the myogenic differentiation study. Labeling of the muscle fibers derived from the mdx ES cells with an anti-dystrophin antibody confirmed the absence of the protein (data not shown).
Mouse ES Cell culture and differentiation. Maintenance. Undifferentiated mouse ES cells were cultured on feeders of mitomycin-C inactivated mouse embryonic fibroblasts at 37 °C in 5% CO 2 , in a maintenance medium composed of DMEM supplemented with 15% fetal bovine serum (Millipore), penicillin, streptomycin, 2 mM l-glutamine, 0.1 mM nonessential amino acids, 0.1% β-mercaptoethanol, 1,500 U/ml LIF and 2i inhibitors 58 . Cells were passaged by trypsinization (Invitrogen). Prior to differentiation, cells were passaged once onto gelatin-coated, feeder-free culture plates.
Serum-free differentiation of mouse ES cells toward a PSM-like fate. ES cells were trypsinized and plated at various densities in gelatin-coated, feeder-free, 96, 24 and 6-well plates directly in serum-free N2B27 medium supplemented with 1% Knock-out Serum Replacement (KSR, Gibco), 0.1% bovine serum albumin (Gibco) and BMP4 at 10 ng/ml (Peprotech) for 2 d. Cells were then changed to a DMEM-based medium, with 15% KSR, supplemented with recombinant 10 ng/ml Rspo3 (Peprotech, R&D Biosystems), 0.5% DMSO (Sigma), and 0.1 µM LDN193189 (Tocris, Miltenyi Biotec/Stemgent) (RDL medium) for 4 d. Alternatively, Rspo3 was replaced with CHIRON99021 (Chir; Tocris, Stemgent) at 1 µM. Differentiation experiments were performed at least 20 times independently.
Serum-free Myogenic differentiation of the mouse PSM-like cells. After the 4 d of culture in RDL or CDL medium, cells were changed to a DMEM-based medium with 15% KSR, 0.1% BSA supplemented with 10 ng/ml HGF, 2 ng/ml IGF-1, 20 ng/ml FGF-2 (Peprotech, R&D Biosystems) and 0.1 µM LDN193189 (HIFL medium) for 2 d. After day 8 of differentiation, only HGF, IGF-1, FGF-2 were supplemented (HIF medium). Media was changed every other day. Long-term differentiation experiments were performed at least 15 times independently, on more than five different mouse ES cell lines.
Human PS cell culture and differentiation. Maintenance. Undifferentiated human hiPS 11a 59 After day 8 of differentiation, cells were cultured in DMEM, 15% KSR, supplemented with 2 ng/ml IGF1 for 4 d, and then supplemented with both 10 ng/ml HGF and 2 ng/ml IGF-1 after day 12. Media was changed every day until day 12, and every second day thereafter. Long-term differentiation experiments were performed at least 15 times independently, on 2 unrelated hiPS and one hES lines. All human iPS and ES cell experiments were done according to local regulations (IGBMC and Brigham and Women's Hospital) and in agreement with national and international guidelines.
Flow cytometry analysis and FACS. Analysis. Cells were dissociated by trypsinization and analyzed by flow cytometry on a FACS calibur (BD Biosciences) according to GFP expression. Gating was determined for each reporter line using corresponding undifferentiated culture as a baseline control. Data are represented as % of GFP + cells in the culture.
Sorting. Msgn1-repV + (M + ) and Pax3-GFP + (P + ) cells were isolated by FACS from Msgn1-repV and Pax3-GFP cells respectively differentiated for 4 d and 6 d in RDL (or CDL) medium. Biological triplicates were generated. Gated fractions were sorted either on FACS Aria (BD Biosciences) or S3 cell sorter (Bio-Rad). Pax7-GFP + cells were isolated from the Pax7-GFP blue ES line differentiated for 3-4 weeks in serum-free medium. Data were further analyzed with the FlowJo software. Sorted populations were either processed for microarray analysis, qRT-PCR or for transplantation experiments.
Quantitative RT-PCR. Total RNA was extracted from ES cell cultures using Trizol (Invitrogen) or with the RNeasy micro-kit (Qiagen). RT-PCR was performed on 5 ng total RNA using QuantiFast SYBR Green RT-PCR Kit (Qiagen) and gene-specific primers (Primerbank) and run on a LightCycler 480II (Roche). Beta-actin was used as an internal control. For mouse tail/PSM reference, mouse E9.5 tails were microdissected posterior to the level of the forming somite (S0) and pooled for total RNA extraction. For embryonic and fetal muscle references, mouse E11.5 trunk muscles and mouse E17.5 back muscles were microdissected for total RNA extraction.
Microarrays generation and analysis. Generation of the PSM microarray series. Microdissections of CD1 mouse E9.5 embryos were done essentially npg as described 61 . Caudo-rostral series of consecutive ~100 µm fragments were collected. 3 series of 7 fragments were generated, from the tail bud to the newly formed somite (S0) level (Fig. 1a,b) . RNA from each fragment was extracted with Trizol (Invitrogen) and used to generate probes hybridized on GeneChip Mouse Genome 430 2.0 arrays.
Microarrays. Biotinylated cRNA targets were prepared from total RNA using a double amplification protocol according to the GeneChip Expression Analysis Technical Manual: Two-Cycle Target Labeling Assay (P/N 701021 Rev.5, Affymetrix, Santa Clara, USA). Following fragmentation, cRNAs were hybridized for 16 h at 45 °C on GeneChip Mouse Genome 430 2.0 arrays. Each microarray was then washed and stained on a GeneChip fluidics station 450 and further scanned with a GeneChip Scanner 3000 7G. Finally, raw data (.CEL Intensity files) were extracted from the scanned images using the Affymetrix GeneChip Command Console (AGCC) version 3.1.
Microarray data analysis. Initial filtering and preprocessing, including background correction, quantile normalization and summarization, was performed using both RMA and MAS with the R Bioconductor package (R version 2.12.1, Bioconductor version 2.8). Expression sets were then filtered according to Calls information. Probe sets expression fold changes between conditions (biological triplicates) were calculated using the "Comparative Marker Selection" module of GenePattern 62 . Volcano and FcFc scatter plots were generated using the Multiplot application of GenePattern. Histogram expression profiles of gene probe sets were generated from MAS values. Further analysis was performed using the Manteia database 63 . Hierarchical clustering was performed on Microarray RMA data. Clustering was computed with an Average linkage method and Euclidean distances. Both an Approximately unbiased (AU) and Bootstrap probability (BP) P values were calculated (pvclust, R package). Clusters with AU and BP P values > 0.95 are highlighted by color-coded boxes.
Cell preparation and transplantation into tibialis anterior muscles. Serumfree cultures of 3-4 week-old differentiated Pax7-GFP blue mouse ES cells were pretreated with ROCK inhibitor (Y-27632, Tocris), one day before trypsin dissociation. Cell preparation was filtered through 30 µm mesh (Partec) and GFP + cells were FACS-sorted. Target cells were resuspended in PBS with tracking fluorescent beads (Molecular probes). 20 µl of cell preparation containing 80,000 to 100,000 cells were injected in the tibialis anterior (TA) muscles of 3-to 4-month-old Rag1 −/− Dmd mdx -5Cv male mice (n = 5). Injections were done under general anesthesia. Grafted TA muscles were collected 1 to 2 months after transplantation and processed for cryosection and immunohistochemistry. Experiments on mice were done according to local regulations (Boston Children's Hospital, Brigham and Women's Hospital, Institut Pasteur, IGBMC), in agreement with national and international guidelines.
In situ hybridization and immunohistochemistry. Whole mount in situ hybridization was carried out as described 64 For immunohistochemistry, cell cultures were fixed for 2 h in 4% formaldehyde. Cultures were rinsed three times in PBS, followed by blocking buffer composed of Tris-buffered saline (TBS) supplemented with 1% FBS and 0.1% Triton X-100. Primary antibodies were then diluted in blocking buffer and incubated overnight at 4 °C. Cultures were then washed three times with TBST (TBS supplemented with 0.5% Tween-20) and incubated with secondary antibodies (1:500) and DAPI (5 µg/ml) in blocking buffer for 2 h. Cultures were ultimately washed with TBST followed by PBS, before analysis. Dissected TA muscles were prepared for cryosections (12 µm) as described 68 . Tissue sections were incubated overnight with primary antibodies in blocking buffer. Secondary antibodies conjugated with AlexaFluor (Molecular probes) were used at 1:500 in blocking buffer.
Antibodies used in this study are anti-Tbx6 (a kind gift of Y. Saga 51 ), anti-dystrophin (Mandra1, Sigma), anti-dystrophin (Dys1, Leica/Novocastra), anti-Myogenin (Dako, DSHB), anti-Pax3 (DSHB), anti-Pax7 (DSHB), anti-Myod1 (Dako), anti-Laminin (Abcam), anti-Titin (DSHB), anti-GFP (Abcam), anti-Fast MyHC (MY-32, Sigma), anti-MyHC (MF20, DSHB) and anti-Ki67 (Abcam).
Membrane permeability assays. Stage-matched 3-to 4-week-old control and mdx ES were cultured as follows. After 4-6 d of culture in RDL medium, cells were changed to a medium supplemented with the FGF inhibitor PD173074 (Sigma) at 250 nM, 0.5% DMSO, and LDN193189 at 0.1 µM. After 2 d of culture in this medium, cells were transferred to a myogenic differentiation medium containing 4 mM l-glutamine, 0.1 mM nonessential amino acids and 2% horse serum (PAA) in DMEM, in which they were maintained for up to 5 weeks. This protocol results in the same myogenic differentiation efficiency as the serum-free protocol described above but leads to less overall cell death resulting in better Evans blue dye staining. Muscle fibers cultures were treated with Evans blue dye (0.2%, Sigma) in N2B27 medium at 37 °C for 45 min. Extra dye was washed away with PBS and cells were reincubated further for 30 min in culture medium, prior to observation. As a permeabilization control, cultures were preincubated with Saponin (Sigma) at 50 µg/ml in culture medium at 4 °C for 20 min prior to staining with Evans blue. Cells were washed with PBS, and cold culture medium was added prior to observation.
Quantifications. Myofibers density count.
A fiber density estimate was calculated by counting the number of fibers in 3-to 4-week-old control cultures. Quantifications were manually done on an average of 5-10 pictures (at 40-100× magnification) per well, acquired from MyHC-stained myofibers fields. Alternatively, staining was quantified by performing automated cell count using the Array scan XTI (Thermofisher) with a 10× objective (144 fields/well). Image analysis was performed with HCS Studio software. Using the Tube Formation Bioapplication we identified fibers according to myosin staining and measured their area, length and width. Three independent differentiation experiments were quantified. Results are expressed as averages of number of fibers per square millimeter.
Myofibers branching quantification. A branching index was calculated by scoring the number of branches per fiber in 3-to 5-week-old control or mdx cultures (two cell lines per genotype). Quantifications were done on an average of 5-10 pictures sets (at 200× magnification) per well, acquired from MyHC and Laminin-stained myofibers fields. Five independent differentiation experiments were scored for branching. A total of 600+ fibers per genotype were scored. Result are expressed in % of fibers.
Myogenic marker quantification. For each marker, immunolabeling was quantified manually on three myogenic fields per well. Alternatively, staining was quantified by performing automated cell count using the Array scan XTI (Thermofisher). Nuclei were segmented using DAPI staining and after a threshold was applied on FITC channel intensity to identify markerpositive cells.
Experiment was performed in triplicate. Result is expressed as a % of positive nuclei.
Image acquisition and processing. Live or fixed brightfield and fluorescent images were acquired either on a Zeiss Axiovert, Evos FL, Zeiss LSM780, or Leica SP5 systems. Images were processed with Adobe Photoshop, and quantification and measurements were done with Fiji 69 software. For muscle contractions, movies were taken with a Leica DMRB microscope using a photometric FX camera and a 20× objective. Images were taken at 100-ms intervals. For movie processing, image sequences were imported and processed in Fiji. Movies were saved in AVI format at a frequency matching the acquisition rate.
Statistical analysis. For array data hierarchical clustering, Approximately unbiased (AU) and BP P values were both calculated (pvclust, R package). Clusters with AU and BP P > 0.95 were considered significant.
For differential array expression data comparison, unpaired t-test P values were calculated using the Comparative Marker Selection module of GenePattern 62 . Differences were considered significant for P values ≤ 0.05.
For qRT-PCR data, unpaired Student t-test and two-tailed P values were calculated. Differences were considered significant for P values ≤ 0.05.
For myofibers branching data, statistical analysis was performed using a Fisher's exact test, based on a 2 × 2 contingency table. Differences between groups were considered significant for P ≤ 0.05. 
